{"nct_id":"NCT01471210","title":"Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2012-02","start_date_type":null,"primary_completion_date":"2016-04","primary_completion_date_type":"ACTUAL","completion_date":"2016-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}